192 related articles for article (PubMed ID: 18973407)
1. Use of fludarabine-containing chemotherapeutic regimen results in durable complete remission of subcutaneous panniculitis-like T-cell lymphoma.
Chim CS; Loong F; Ng WK; Kwong YL
Am J Clin Dermatol; 2008; 9(6):396-8. PubMed ID: 18973407
[TBL] [Abstract][Full Text] [Related]
2. Aggressive subcutaneous panniculitis-like T-cell lymphoma: complete remission with fludarabine, mitoxantrone and dexamethasone.
Au WY; Ng WM; Choy C; Kwong YL
Br J Dermatol; 2000 Aug; 143(2):408-10. PubMed ID: 10951154
[TBL] [Abstract][Full Text] [Related]
3. Subcutaneous panniculitis-like T-cell lymphoma: complete remission with fludarabine.
Go RS; Gazelka H; Hogan JD; Wester SM
Ann Hematol; 2003 Apr; 82(4):247-50. PubMed ID: 12707730
[TBL] [Abstract][Full Text] [Related]
4. Subcutaneous panniculitis-like T-cell lymphoma with unusual eschar-like crusting.
Ghosh SK; Roy D; Mondal P; Bhunia D; Dutta DP
Dermatol Online J; 2014 Feb; 20(2):. PubMed ID: 24612568
[TBL] [Abstract][Full Text] [Related]
5. [Experience with fludarabine treatment and review of the literature].
Telek B; Rejtó L; Kiss A; Batár P; Reményi G; Rák K; Udvardy M
Orv Hetil; 2002 Jun; 143(24):1459-65. PubMed ID: 12138643
[TBL] [Abstract][Full Text] [Related]
6. Pediatric Subcutaneous Panniculitis-like T-Cell Lymphoma With Hemophagocytosis Showing Complete Resolution With the BFM90 Protocol: Case Report and Review of Literature.
Singh S; Philip CC; John MJ
J Pediatr Hematol Oncol; 2019 Aug; 41(6):478-481. PubMed ID: 30730380
[TBL] [Abstract][Full Text] [Related]
7. Fludarabine, mitoxantrone, and dexamethasone: an effective new regimen for indolent lymphoma.
McLaughlin P; Hagemeister FB; Romaguera JE; Sarris AH; Pate O; Younes A; Swan F; Keating M; Cabanillas F
J Clin Oncol; 1996 Apr; 14(4):1262-8. PubMed ID: 8648382
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of a rare subcutaneous panniculitis-like T-cell lymphoma: An unusual case report and literature review.
Xu L; Che Y; Ding X; Song J; Zhang X; Sun X
Dermatol Ther; 2019 May; 32(3):e12878. PubMed ID: 30884048
[No Abstract] [Full Text] [Related]
9. Myelodysplasia and acute myeloid leukemia following therapy for indolent lymphoma with fludarabine, mitoxantrone, and dexamethasone (FND) plus rituximab and interferon alpha.
McLaughlin P; Estey E; Glassman A; Romaguera J; Samaniego F; Ayala A; Hayes K; Maddox AM; Preti HA; Hagemeister FB
Blood; 2005 Jun; 105(12):4573-5. PubMed ID: 15741224
[TBL] [Abstract][Full Text] [Related]
10. Low-grade non-Hodgkin's lymphoma--development of a new effective combination regimen (fludarabine, mitoxantrone and dexamethasone; FND).
Keating MJ; McLaughlin P; Cabanillas F
Eur J Cancer Care (Engl); 1997 Dec; 6(4 Suppl):21-6. PubMed ID: 9460339
[TBL] [Abstract][Full Text] [Related]
11. High ten-year remission rates following rituximab, fludarabine, mitoxantrone and dexamethasone (R-FND) with interferon maintenance in indolent lymphoma: Results of a randomized Study.
Nastoupil LJ; McLaughlin P; Feng L; Neelapu SS; Samaniego F; Hagemeister FB; Ayala A; Romaguera JE; Goy AH; Neal E; Wang M; Fayad L; Fanale MA; Oki Y; Westin JR; Rodriguez MA; Cabanillas F; Fowler NH
Br J Haematol; 2017 Apr; 177(2):263-270. PubMed ID: 28340281
[TBL] [Abstract][Full Text] [Related]
12. Unraveling subcutaneous panniculitis-like T-cell lymphoma: An association between subcutaneous panniculitis-like T-cell lymphoma, autoimmune lymphoproliferative syndrome, and familial hemophagocytic lymphohistiocytosis.
LeBlanc RE; Lansigan F
J Cutan Pathol; 2021 Apr; 48(4):572-577. PubMed ID: 32894575
[TBL] [Abstract][Full Text] [Related]
13. Systemic corticosteroids for subcutaneous panniculitis-like T-cell lymphoma.
Guenova E; Schanz S; Hoetzenecker W; DeSimone JA; Mehra T; Voykov B; Urosevic-Maiwald M; Berneburg M; Dummer R; French LE; Kerl K; Kamarashev J; Fierlbeck G; Cozzio A
Br J Dermatol; 2014 Oct; 171(4):891-4. PubMed ID: 24725144
[TBL] [Abstract][Full Text] [Related]
14. Chidamide induces long-term remission in rare subcutaneous panniculitis-like T-cell lymphoma: An unusual case report and literature review.
Li L; Wu C; Chai Y; Dong C; Zhao L
Int J Immunopathol Pharmacol; 2021; 35():20587384211009342. PubMed ID: 33845613
[TBL] [Abstract][Full Text] [Related]
15. Phase I study of the combination of fludarabine, mitoxantrone, and dexamethasone in low-grade lymphoma.
McLaughlin P; Hagemeister FB; Swan F; Cabanillas F; Pate O; Romaguera JE; Rodriguez MA; Redman JR; Keating M
J Clin Oncol; 1994 Mar; 12(3):575-9. PubMed ID: 8120556
[TBL] [Abstract][Full Text] [Related]
16. [Preliminary report of fludarabine, mitoxantrone and dexamethasone in treating refractory or relapsed multiple myeloma].
Luo SK; Li J; Hong WD; Zhao Y; Tong XZ
Ai Zheng; 2005 Dec; 24(12):1518-21. PubMed ID: 16351805
[TBL] [Abstract][Full Text] [Related]
17. Immunophenotypic and molecular features, clinical outcomes, treatments, and prognostic factors associated with subcutaneous panniculitis-like T-cell lymphoma: a systematic analysis of 156 patients reported in the literature.
Go RS; Wester SM
Cancer; 2004 Sep; 101(6):1404-13. PubMed ID: 15368328
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppression and infectious complications in patients with stage IV indolent lymphoma treated with a fludarabine, mitoxantrone, and dexamethasone regimen.
Tsimberidou AM; Younes A; Romaguera J; Hagemeister FB; Rodriguez MA; Feng L; Ayala A; Smith TL; Cabanillas F; McLaughlin P
Cancer; 2005 Jul; 104(2):345-53. PubMed ID: 15948158
[TBL] [Abstract][Full Text] [Related]
19. Subcutaneous panniculitis-like T-cell lymphoma in children: a detailed clinicopathological description of 11 multifocal cases with a high frequency of haemophagocytic syndrome.
Oschlies I; Simonitsch-Klupp I; Maldyk J; Konovalov D; Abramov D; Myakova N; Lisfeld J; Attarbaschi A; Kontny U; Woessmann W; Klapper W
Br J Dermatol; 2015 Mar; 172(3):793-7. PubMed ID: 25456748
[No Abstract] [Full Text] [Related]
20. [Clinical analysis of 10 patients with subcutaneous panniculitis-like T cell lymphoma].
Wang SH; Wang QS; Sun L; Li HH; Zhao Y; Jia BJ; Tian JX; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):926-9. PubMed ID: 23998587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
